CellaVision
150.60 SEK
+0.53 %
1,475 following
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 178.7 | 186.7 | 723.2 | 194.8 | 191.3 | 175.6 | 197.2 | 759.0 |
| EBITDA | 48.8 | 61.3 | 219.0 | 66.5 | 59.6 | 49.8 | 65.5 | 241.4 |
| EBIT | 38.4 | 51.3 | 177.7 | 57.1 | 50.3 | 39.5 | 55.1 | 202.1 |
| EBIT-% | 21.5 % | 27.5 % | 24.6 % | 29.3 % | 26.3 % | 22.5 % | 27.9 % | 26.6 % |
| Profit before taxes | 38.9 | 51.5 | 176.9 | 52.5 | 48.0 | 39.2 | 54.5 | 194.3 |
| Net income | 31.1 | 40.9 | 140.7 | 41.5 | 37.6 | 31.3 | 42.6 | 153.1 |